Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026)
Protalix BioTherapeutics (PLX) reported Interest & Investment Income of $660,000 for Q2 2026, up 142.6% from $272,000 a year earlier and up 251.1% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Protalix BioTherapeutics' Interest & Investment Income came in at $1.4 million, up 13.9% year-over-year; for FY2025, it came in at $1.08 million, down 16.6% from FY2024.
- By year, Interest & Investment Income came in at $1.3 million in FY2024 (+1.0%) and $1.29 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q2 2024.
- Year over year, Interest & Investment Income gained in two of the last five quarters, with growth averaging 15.5%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $188,000 (Q1 2026), $266,000 (Q4 2025) and $289,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Protalix BioTherapeutics | 205.46 Mn | 54.08 Mn | 12.13 Mn | 660,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 660,000.00 |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 266,000.00 |
| Sep 30, 2025 | 289,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 212,000.00 |
| Jun 30, 2024 | 374,000.00 |
API Access
Protalix BioTherapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();